Norazah A, Rohani M Y, Chang P T, Kamel A G
Institute for Medical Research, Kuala Lumpur, Malaysia.
Southeast Asian J Trop Med Public Health. 1996 Jun;27(2):263-6.
Interpretation of the indirect hemagglutination test (IHA) for melioidosis in endemic areas is difficult because of the presence of antibodies in apparently healthy individuals. Fifty-three out of 200 healthy blood donors in Malaysia showed positive antibody titers (> or = 1 : 40) against Burkholderia pseudomallei. Seven percent had an IHA titer of 1 : 40, 11% had an IHA titer of 1 : 80 while 8.5% had a titer > or = 1 : 160. Out of 258 sera sent for melioidosis serology, 7% of the patients had an IHA titer of 1 : 40, 9% had an IHA titer of 1 : 80 while 20% had an IHA titer of > or = 1 : 160. If a titer of > or = 1 : 80 is taken as cut off point for positivity, 29% of the patients had positive melioidosis serology. Increasing the positivity threshold may jeopardize the sensitivity of the test. A more specific and sensitive test is needed.
在地方性流行区,由于健康个体中存在抗体,类鼻疽间接血凝试验(IHA)的结果解读存在困难。马来西亚200名健康献血者中,有53人对类鼻疽伯克霍尔德菌的抗体滴度呈阳性(≥1:40)。7%的人IHA滴度为1:40,11%的人IHA滴度为1:80,而8.5%的人滴度≥1:160。在送去做类鼻疽血清学检测的258份血清中,7%的患者IHA滴度为1:40,9%的患者IHA滴度为1:80,而20%的患者IHA滴度≥1:160。如果将≥1:80的滴度作为阳性判定值,29%的患者类鼻疽血清学检测呈阳性。提高阳性阈值可能会损害检测的敏感性。因此需要一种更特异、更敏感的检测方法。